DocGo (NASDAQ:DCGO) Stock Rating Reaffirmed by Needham & Company LLC

DocGo (NASDAQ:DCGO – Get Rating)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $14.00 price target on the stock. Needham & Company LLC’s target price indicates a potential upside of 69.49% from the stock’s current price.

DocGo Stock Performance

Shares of DCGO opened at $8.26 on Tuesday. DocGo has a 12 month low of $4.96 and a 12 month high of $11.41. The stock has a fifty day moving average price of $8.97 and a 200-day moving average price of $8.81. The company has a current ratio of 3.54, a quick ratio of 3.54 and a debt-to-equity ratio of 0.01. The firm has a market cap of $845.91 million, a PE ratio of 25.81 and a beta of 0.97.

DocGo (NASDAQ:DCGO – Get Rating) last released its earnings results on Monday, March 13th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.06. DocGo had a return on equity of 16.14% and a net margin of 10.34%. The firm had revenue of $108.79 million for the quarter, compared to the consensus estimate of $104.13 million. During the same period in the prior year, the firm earned $0.17 EPS. Equities research analysts predict that DocGo will post 0.29 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Alliancebernstein L.P. increased its holdings in DocGo by 27.0% in the 4th quarter. Alliancebernstein L.P. now owns 77,100 shares of the company’s stock valued at $545,000 after purchasing an additional 16,400 shares during the last quarter. State of Wyoming purchased a new stake in DocGo in the fourth quarter valued at $50,000. Rayliant Investment Research purchased a new stake in DocGo in the fourth quarter valued at $208,000. Lazard Asset Management LLC acquired a new position in DocGo in the fourth quarter valued at $64,000. Finally, Susquehanna Fundamental Investments LLC acquired a new position in DocGo in the fourth quarter valued at $107,000. 36.88% of the stock is owned by hedge funds and other institutional investors.

DocGo Company Profile

(Get Rating)

DocGo, Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.